Tumor-LN-oC at the Regenerative Medicine workshop 12.10.22 in Prague

July 20, 2022

Tumor-LN-oC partner AMIRES is organising the 2nd Regenerative Medicine workshop which will take place on Wednesday, October 12th 2022, in Prague.

During the workshop, different EU-funded projects will present their expected outputs, the status of their development, target applications, and challenges in the exploitation of these technologies. Also Tumor-LN-oC will be present: team members will introduce the project and its objectives, discuss the progress, challenges and potential exploitation routes.

The goal of the event is to bring together different projects and initiatives in the field of regenerative medicine to exchange project outcomes and experiences in the development of technologies in the regenerative medicine field, as well as to build partnerships for commercialization and clinical introduction of the individual project outcomes and/or for further research projects. A special focus will be on the needs and opportunities for further collaborations and the importance of health economics assessment/analysis.

Participation is free of charge and open for all. Registrations are now open here. We are looking forward to see you there!

Other news
Tumor-LN-oC project has kicked-off!
August 18, 2021
On May 7th, 2021 Tumor-LN-oC project (Tumor and Lymph Node on Chip for cancer studies) was officially kicked-offvia online conferencing service where
Tumor-LN-oC´s first PRESS RELEASE
September 2, 2021
European (EU) H2020 funded Tumor-LN-oC project, officially started on 1st May, 2021, Tumor-LN-oC proposes the development and validation of tumor-lymph node-on
6 months completed!
November 24, 2021
On the 18th and 19th of November, the Tumor-LN-oC consortium met for the M6 meeting in Athens. The meeting closed the first half year of project implementation
Questionnaire for Tumor-LN-oC end-users
January 10, 2022
To better understand the end-user requirements for the tumor-lymph node-on-chip platform, that will be developed during the course of the project, we have prepa
Tumor-LN-oC completes selection of materials and processes
March 25, 2022
With the conclusion of Month 10 of the project, Tumor-LN-oC consortium successfully passed the second milestone of the project: the final selection of specifica